|
Press Releases |
|
|
|
Friday, September 23, 2022 |
|
Malaysian Genomics Grows Presence in Thailand |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce today a series of collaborations to grow its customer base in Thailand as well as exploring opportunities for research and development (R&D) of new products and services. more info >> |
|
Wednesday, September 21, 2022 |
|
Malaysian Genomics, Rinani Genotec Sign LOI with Universiti Malaysia Sabah |
Leading genomics and biopharmaceutical specialist Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155) is pleased to report that the Group has signed a letter of intent (LOI) with the Faculty of Science and Natural Resources, Universiti Malaysia Sabah (UMS) and Rinani Genotec Sdn Bhd (Genotec) to collaborate on research and development (R&D) in genetics, and regenerative and alternative medicines. more info >> |
|
Tuesday, August 30, 2022 |
|
Malaysian Genomics Reports RM28.36 Million Full-Year Revenue |
Malaysian Genomics Resource Centre Berhad, a leading genomics and biopharmaceutical specialist, reported revenue of RM6.33 million for the fourth quarter ended 30 June 2022 (4Q 2022) compared with the loss of RM0.07 million in the corresponding quarter of the previous financial year (4Q 2021) on higher contribution from the biopharmaceutical business and continued organic growth of the genetic testing business. more info >> |
|
Monday, August 29, 2022 |
|
Malaysian Genomics Signs MoU with Ajlan to explore distribution of biopharmaceutical and genetic screening services in MENA region |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, today announced that the Group has signed a Memorandum of Understanding (MoU) to explore opportunities for the distribution of biopharmaceutical and genomics products and services with Ajlan & Bros Medical Company. more info >> |
|
Thursday, August 18, 2022 |
|
Malaysian Genomics Explores Strategic Partnership with MAHSA Health through MoU |
Malaysian Genomics Resource Centre Berhad's (Bursa: MGRC, 0155) wholly-owned subsidiary, MGRC Therapeutics Sdn. Bhd. signed a memorandum of understanding (MoU) with MAHSA Health Sdn Bhd to discuss the formation of a strategic partnership promoting practice-based education, research and knowledge exchange. more info >> |
|
Wednesday, July 20, 2022 |
|
UCrest Partners with Malaysian Genomics to Digitalize Genome Services Worldwide |
UCrest Berhad (ACE Market: 0005) and Malaysian Genomics Resources Centre Berhad, (ACE Market: 0155) announced today that they have signed a collaborative agreement to integrate genomic testing services into digital health platform, iMedic(TM), elevating healthcare services to the next level. more info >> |
|
Friday, July 15, 2022 |
|
Malaysian Genomics Appoints New Chairman |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Company has appointed Dato' Seri Dr Chen Chaw Min as the Independent Non-Executive Chairman of the Board of Directors. more info >> |
|
Wednesday, July 13, 2022 |
|
Malaysian Genomics Forms Partnership for Expansion in Saudi Arabia |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that it has entered into a strategic partnership with United Doctors Hospital (UDH) for collaboration in genomics and cell therapies. more info >> |
|
Friday, July 8, 2022 |
|
Malaysian Genomics Proposes Private Placement |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, announced today that the Group is proposing to undertake a private placement of up to 10% of its total number of issued shares or up to 12.42 million new placement shares at an issue price to be determined for third-party investors that will be identified later. more info >> |
|
Wednesday, July 6, 2022 |
|
Malaysian Genomics to Offer First-Ever Sports-Based Tests Specific to Southeast Asian Genetic Profiles |
Malaysian Genomics Resource Centre Berhad (Bursa: MGRC, 0155), a leading genomics and biopharmaceutical specialist, is pleased to announce that the Group's wholly-owned subsidiary, MGRC Therapeutics Sdn Bhd (MGRCT), is collaborating with Rinani Genotec Sdn Bhd (Genotec) to offer sports-based genetic tests. more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Eastern River Pty Ltd Forecasts Strong Growth in the Global Corporate Bond Market in 2024, with Australian Bonds Also Showing Resilience
Dec 10, 2024 14:45 HKT/SGT
|
|
|
Q2 Metals Drills 188.6 M Grading 1.56% Li2O, including 26 Metres of 2.03% Li2O, at the Cisco Lithium Property, James Bay, Quebec, Canada
Dec 10, 2024 14:30 HKT/SGT
|
|
|
THE TRIFECTA FUNHOUSE Brings Orchard Road Alive with a Free New Year's Eve Celebration!
Dec 10, 2024 11:50 HKT/SGT
|
|
|
Fujitsu drives business process improvement at Mitsubishi Electric Engineering using SAP Signavio(R)
Dec 10, 2024 11:38 JST
|
|
|
Kincora Announces Shareholder Meeting Results
Dec 10, 2024 08:59 HKT/SGT
|
|
|
Friedman Institute Releases Report on "Analysis on Libyan Oil and Gas Supply - Italy's Strategic Role in Mediterranean Energy"
Dec 10, 2024 08:30: JST
|
|
|
Friedman Institute Releases Report on "Analysis on Libyan Oil and Gas Supply - Italy's Strategic Role in Mediterranean Energy"
Dec 10, 2024 07:30 HKT/SGT
|
|
|
Lexaria Reports: Liraglutide Processed with DehydraTECH to be Studied in Human GLP-1 Study #5
Dec 9, 2024 22:10 HKT/SGT
|
|
|
HAIN Premieres December 13, Showcasing the Power of Turkish Cinema
Dec 9, 2024 23:00 JST
|
|
|
Fourteen new trains to drive first rail open access growth
Dec 9, 2024 20:10 JST
|
|
|
Hitachi to supply Japan's first SF6-free 300 kV circuit-breakers to Chubu Electric Power Grid
Dec 9, 2024 19:13 JST
|
|
|
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China
Dec 9, 2024 14:00: JST
|
|
|
NEC begins sale of 100G QSFP28 ZR4 single-fiber bi-directional optical transceiver
Dec 9, 2024 14:06 JST
|
|
|
China Medical System: First Prescriptions for Innovative Drug Lumeblue(R) Issued in China
Dec 9, 2024 13:00 HKT/SGT
|
|
|
Hitachi, NTT Com Successfully Demonstrate World's First Real-Time Data Synchronization Over 600 km Using Storage Virtualization Technology and IOWN APN
Dec 9, 2024 12:00 JST
|
|
|
|
More News >> |
|
|
|
|
|